HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
MEILLEURHEALTH (02327) Spent HKD 590,400 to repurchase 1,998,000 shares on January 6th.
06/01/2025
GMT Eight
MEILLEUREHEALTH (02327) announced on January 6, 2025 that it would spend HK$590,400 to repurchase 1,998,000 shares.
Cultural Investment Holdings (600715.SH): The delisting risk warning that was implemented due to restructuring has been revoked.
JUNSHI BIO (01877): Tepilumab, a second-line and above treatment for melanoma, receives regular approval from the National Medical Products Administration.
RECOMMEND
Flowco Holdings (FLOC.US) announced plans for an IPO, intending to raise $392 million.
07/01/2025
US Stock Market Move | Concept stocks of cryptocurrencies have fallen sharply, with Bitcoin briefly dropping below $99,000.
07/01/2025
The rapid growth in the business services sector has driven the number of job vacancies in the United States to the highest level in six months in November.
07/01/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com